Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MyNurse ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   8.3% 6.8% 3.6% 4.8% 4.1% 1.9% 14.3% 14.3%   Credit score (0-100)   31 36 52 43 49 69 15 15   Credit rating   BB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,369 2,912 4,206 6,685 3,185 6,487 0.0 0.0   EBITDA   393 256 1,875 3,810 673 2,188 0.0 0.0   EBIT   393 256 1,875 3,810 673 2,138 0.0 0.0   Pre-tax profit (PTP)   394.1 257.4 1,879.0 3,891.9 710.4 2,139.8 0.0 0.0   Net earnings   288.8 188.4 1,457.1 3,024.4 545.8 1,757.4 0.0 0.0   Pre-tax profit without non-rec. items   394 257 1,879 3,892 710 2,140 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 452 0.0 0.0   Shareholders equity total   339 238 1,507 3,074 596 1,807 0.0 0.0   Interest-bearing liabilities   0.0 0.0 5.3 5.3 111 12.9 0.0 0.0   Balance sheet total (assets)   442 426 2,783 4,388 1,184 2,802 0.0 0.0   Net Debt   -246 -215 -1,651 -905 -879 -1,379 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,369 2,912 4,206 6,685 3,185 6,487 0.0 0.0   Gross profit growth   -25.4% 22.9% 44.4% 58.9% -52.4% 103.7% -100.0% 0.0%   Employees   2 2 2 3 3 5 0 0   Employee growth %   -33.3% 0.0% 0.0% 50.0% 0.0% 66.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   442 426 2,783 4,388 1,184 2,802 0 0   Balance sheet change%   -64.7% -3.5% 553.1% 57.7% -73.0% 136.6% -100.0% 0.0%   Added value   392.5 256.4 1,875.0 3,810.0 673.4 2,188.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 402 -452 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.6% 8.8% 44.6% 57.0% 21.1% 33.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.6% 59.6% 117.3% 109.1% 25.9% 107.9% 0.0% 0.0%   ROI %   65.6% 89.7% 215.1% 170.3% 38.2% 170.2% 0.0% 0.0%   ROE %   48.0% 65.3% 167.0% 132.0% 29.7% 146.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   76.7% 55.9% 54.1% 70.1% 50.3% 64.5% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -62.7% -83.7% -88.0% -23.7% -130.5% -63.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.4% 0.2% 18.6% 0.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 150.3% 365.7% 21.6% 16.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.3 2.3 2.2 3.3 2.0 2.4 0.0 0.0   Current Ratio   4.3 2.3 2.2 3.3 2.0 2.4 0.0 0.0   Cash and cash equivalent   246.2 214.6 1,655.9 910.1 989.9 1,392.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   338.8 238.4 1,507.1 3,074.4 595.8 1,354.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   196 128 938 1,270 224 438 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   196 128 938 1,270 224 438 0 0   EBIT / employee   196 128 938 1,270 224 428 0 0   Net earnings / employee   144 94 729 1,008 182 351 0 0